The trial design is as much as an art as it is a science.
I believe SI was a former advisor for the FDA and has used his knowledge of the FDA to design the all our trials e.g. start with aGVHD as an orphan drug indication, this was deliberately chosen as our first product to go through the BLA process to enhance our chance of approval
MSB Trading 2020 - a new dawn, page-2064
-
- There are more pages in this discussion • 11,007 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |